Results 221 to 230 of about 97,791 (283)

Coronary microvascular disease in heart failure with preserved ejection fraction. [PDF]

Physiol Rep
Sen P, Wang L, d'Ambrosio L, Bierschenk S, Hamers J, Ornek I, Sittig T, Zhang H, Zhang J, Merkus D.   +9 more
europepmc   +1 more source

Interface Engineering in Solid‐State Sodium Batteries: Advances in Materials Design, Interfacial Strategies, and Multiscale Characterization

Interdisciplinary Materials, EarlyView.
Since solid‐state sodium batteries (SSSBs) are a promising solution for advancing sodium‐based energy storage, it is necessary to systematically summarize the development process of SSSBs. It focuses on the role of interface engineering in addressing challenges such as materials design, interfacial strategies, and multiscale characterization.
Yonghuan Fu, Guosheng Shao, Yong Lei
wiley   +1 more source

Body composition in patients with obesity-related heart failure with preserved ejection fraction: A comparison study. [PDF]

JPEN J Parenter Enteral Nutr
Salmons H, Ahmed SI, Billingsley HE, Reavey-Cantwell A, Markley R, Golino M, Del Buono MG, Damonte JI, Pinel S, Franco RL, Abbate A, Earthman CP, Carbone S.   +12 more
europepmc   +1 more source

Adipose‐derived small extracellular vesicles exacerbate microvascular dysfunction in heart failure with preserved ejection fraction via mmu‐miR‐582‐3p‐mediated Rap1b suppression

Interdisciplinary Medicine, EarlyView.
This study reveals that small extracellular vesicles (sEVs) from visceral fat compromise coronary microcirculation in a mouse model of heart failure with preserved ejection fraction (HFpEF). The SGLT2 inhibitor canagliflozin emerges as a therapeutic strategy, improving cardiac function and endothelial health.
Lu Chen, Qiuhan Wang, Mengjia Shen, Mingjue Li, Yingqi Zhu, Cankun Zheng, Siyuan Ma, Hairuo Lin, Xiaokang Fu, Rui Zhang, Jianping Bin, Yulin Liao, Qiancheng Wang   +12 more
wiley   +1 more source

Heart Failure With Preserved Ejection Fraction: A Case of Cardiac Amyloidosis and the Importance of Echocardiography in the Diagnostic Workup of Infiltrative Disease. [PDF]

Cureus
Shah P, Murphy KN, Simo S, Alvarado A, Vanhecke T.   +4 more
europepmc   +1 more source

Preoperative visceral fat and muscle loss after cardiovascular surgery: A retrospective cohort study

Journal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Patients with visceral obesity experience an amplified systemic inflammatory response during the perioperative period, increasing infection risk. Significant skeletal muscle loss following invasive cardiovascular surgery presents a considerable clinical challenge.
Kazuya Shimizu, Ryota Matsuzawa, Shinya Nakamura, Hiroyuki Miyoshi, Keita Murakawa, Hideo Kawakami, Ryohei Mineo, Yasuko Gotake, Motoaki Ohnaka, Masamichi Matsumori, Akira Tamaki   +10 more
wiley   +1 more source

Vascular function in women with heart failure with preserved ejection fraction: a mismatch beyond diastole. [PDF]

J Appl Physiol (1985)
Carlini NA, Wray DW, Moreau KL, Bunsawat K.   +3 more
europepmc   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

Predicting 30-day and 1-year mortality in heart failure with preserved ejection fraction (HFpEF). [PDF]

PLoS One
Shin I, Bhatt N, Alashi A, Kandala K, Murugiah K.   +4 more
europepmc   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source